COVID-19 vaccination in patients with multiple sclerosis receiving disease-modifying therapies: pragmatic issuesArticle Published on 2022-12-012023-07-11 Journal: Drugs of today (Barcelona, Spain : 1998) [Category] COVID19(2023년), [키워드] Acute relapse cerebrovascular disorders COVID-19 vaccination Demyelinating diseases Disease-modifying therapies immune response Maxillo-facial involvement multiple sclerosis. [DOI] 10.1358/dot.2022.58.12.3455368 PMC 바로가기
To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infectionObservational Study Published on 2022-09-012022-10-05 Journal: Multiple sclerosis and related disorders [Category] 바이오마커, 임상, [키워드] Acute relapse age BNT162b2 Central nervous system COVID-19 COVID-19 infection COVID-19 vaccination demyelinating disorder determine disease disorder eight evaluate group immune-mediated diseases incidence increase in Infection interval Lower Mild morbidity and mortality Multiple multiple sclerosis Neuromyelitis Neuromyelitis Optica Observational cohort study Patient post-COVID-19 patient proportion retrospective risk risk factor Risk factors vaccination vaccination. was collected [DOI] 10.1016/j.msard.2022.104014 PMC 바로가기 [Article Type] Observational Study
COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose다발성 경화증 환자의 코로나19 백신 접종: 3차 추가 접종의 안전성 및 체액 효능Article Published on 2022-03-152022-09-12 Journal: Journal of the neurological sciences [Category] MERS, SARS, 진단, [키워드] Acute relapse Administered Adverse adverse event adverse events booster booster dose country COVID-19 COVID-19 vaccination dose doses Efficacy evaluated fatigue Fever Frequency humoral humoral immune response immune response Immunity increase in increased risk injection IQR joint large cohort local pain median mRNA vaccination Multiple multiple sclerosis of BNT162b2 Pain Patient patients patients treated reported risk Safe Safety SARS-CoV-2 IgG second dose significant increase steroid Symptom Third booster dose Transient treated Treatment vaccination vaccination. Vaccine vaccine administration [DOI] 10.1016/j.jns.2022.120155 PMC 바로가기 [Article Type] Article
Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case ReportNeurology Published on 2021-08-102022-11-01 Journal: Frontiers in Neurology [Category] COVID-19, [키워드] Acute relapse BNT162b2 vaccine Case report Cladribine clinical condition COVID-19 COVID-19 vaccination COVID-19 vaccination programme COVID-19 vaccine COVID-19 vaccines Diagnosis implementation IMPROVE Italy knowledge lesions limbs Methylprednisolone MRI mRNA Multiple multiple sclerosis National neurological Neurological symptom paraesthesia Patient pharmacological receiving recommendations Relapse report sclerosis South the patient the vaccine therapy weakness [DOI] 10.3389/fneur.2021.721502 PMC 바로가기 [Article Type] Neurology